Business

Invion Doses First Patient in Phase I/II Skin Cancer Trial

Invion Doses First Patient in Phase I/II Skin Cancer Trial

Invion Ltd.December 2, 20245

Invion Doses First Patient in Phase I/II Skin Cancer Trial

About this update from Invion Ltd.

Invion Ltd has released a press release. View Attachment

View stock analysis, news, and events for Invion Ltd.

More from Invion Ltd.

Appendix 4C and Quarterly Activities Report - June 2026

July 30, 2026

Photosoft Platform Expands to Eye Diseases Via Partnership

May 18, 2026

All Invion Ltd. news →